Delivery Order SPE2DB22D3004-SPE2DB23FRD84
Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,283.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561484009 Eleptiriptan HBR 40 MG tablets. The single day order is to be fulfilled on July 13, 2023 with performance taking place in Conshohocken, Pennsylvania. DLA handles medical commodity procurement for the Department of Defense, stocking pharmaceuticals and other medical supplies used by military treatment facilities worldwide. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $1,360.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561625383 Eleptiriptan HBR 40 MG tablets. The single award delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products to DLA locations. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 27 to July 28, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $11,866 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562031497 Eleptiriptan HBR 40 MG tablets. The order is for an unspecified quantity of the medication to be delivered to a Conshohocken, Pennsylvania facility by September 5, 2023. As a major supplier of pharmaceuticals and medical supplies to support Department of Defense health programs worldwide, this order for migraine relief medication is consistent with DLA's mission...
- The Defense Logistics Agency awarded a $977.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561479899 Eleptiriptan HBR 40 MG tablets. The order is for a quantity of six units to be delivered to the prime contractor's facility in Conshohocken, Pennsylvania by July 13, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure essential supplies and services are available to the armed forces. This small order...
- The Defense Logistics Agency awarded a $1,529 delivery order to Amerisourcebergen Drug Corporation for 4561271827 Eleptiriptan HBR 40 MG tablets. As the prime contractor, Amerisourcebergen will deliver the medication to a facility in Conshohocken, Pennsylvania under a firm fixed price contract starting on June 16, 2023 and concluding on June 20, 2023. The Defense Logistics Agency is a combat support agency under the Department of Defense that provides supplies to all branches of the military....
- The Defense Logistics Agency Troop Support Medical awarded a $813 delivery order to Amerisourcebergen Drug Corporation for 40mg Eleptiriptan tablets. The firm fixed price order is for a one-day period of performance from July 20-21, 2023 at the contractor's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
- The Defense Logistics Agency awarded a $811 delivery order to Amerisourcebergen Drug Corporation for 20 mg tablets of eleptiriptan HBR under firm fixed price terms. Performance will take place in Conshohocken, Pennsylvania over a one day period concluding on September 1, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will supply the eleptiriptan HBR tablets to the Defense Logistics Agency, the logistics combat support agency of the Department of Defense, in support of its...
- The Defense Logistics Agency awarded a $408 delivery order to Amerisourcebergen Drug Corporation for eleptiriptan hydrobromide 40mg tablets. The firm fixed price order calls for delivery of the pharmaceutical product to a facility in Conshohocken, Pennsylvania by June 28, 2023. As a major supplier of medical materiel to the Department of Defense, Amerisourcebergen will fulfill this requirement for the migraine treatment medication in support of DLA's logistics operations. No set aside provisions...
- The Defense Logistics Agency awarded a $408,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561504098 Eleptiriptan HBR 40 MG tablets. The order is for an unspecified quantity of the medication to be delivered to a DLA facility in Conshohocken, Pennsylvania by July 17, 2023. As a major component of the Defense Department that manages global logistics operations for the military services, DLA supports procurement and distribution of pharmaceuticals and other...
- The Defense Logistics Agency awarded a $255,830 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562162383 Eleptiriptan HBR 40 MG tablets. As the prime contractor, Amerisourcebergen will supply the migraine medication to DLA from its facility in Conshohocken, Pennsylvania under a one day period of performance between September 13-14, 2023. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FRD84Delivery Order
The Defense Logistics Agency awarded a $1,817 delivery order to Amerisourcebergen Drug Corporation for eleptiriptan hydrobromide 40mg tablets. The firm fixed price order is for a one-day period of performance from August 30th to August 31st, 2023, with all work taking place in Conshohocken, Pennsylvania. DLA handles logistics for the Department of Defense, procuring pharmaceuticals and other medical supplies to support military treatment facilities. No set aside designation or subcontractors were indicated. The order is a small transaction under an existing DLA pharmaceuticals contract vehicle.
Generated 12/15/23, 4:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/30/23 |